Tracy Williams

Tracy Williams, PhD, DABT, is the Vice President of ADME/Toxicology/PKPD at Eli Lilly and Company, where they lead efforts in drug disposition and toxicology. They previously held several roles at Eli Lilly, including Senior Director and Associate Vice President, overseeing critical projects such as the Loxo Oncology portfolio. Tracy completed a PhD in Pharmaceutical Sciences with a focus on Toxicology from the University of Connecticut and earned a BS in Forensic Chemistry from Ohio University. They began their career as a Postdoctoral Fellow at the Chemical Industry Institute of Toxicology.